Symbols

NRIX

Nurix Therapeutics·NASDAQ

--(--)

NRIX fundamentals

NRIX Q2 2025 Earnings

Nurix Therapeutics (NRIX) released its earnings on Jul 9, 2025: revenue was 44.06M (YoY +264.34%), beat estimates; EPS was -0.52 (YoY +26.76%), beat estimates.

Revenue / YoY

44.06M

+264.34%

EPS / YoY

-0.52

+26.76%

Report date

Jul 9, 2025

Earnings Call

4:00 PM on Jul 7, 2025

Meeting link.

Earnings

EPS

Revenue

Revenue & Expenses

NRIX has released its 2025 Q4 earnings report, with revenue of 13.58M, reflecting a YoY change of 2.21%, and net profit of -78.22M, showing a YoY change of -33.60%. The Sankey diagram below clearly presents NRIX's revenue sources and cost distribution.

Key Indicators

Nurix Therapeutics (NRIX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Nurix Therapeutics (NRIX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Nurix Therapeutics (NRIX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Nurix Therapeutics (NRIX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown